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Abstract
Background—The Alaska Native (AN) population experiences twice the incidence and 
mortality of colorectal cancer (CRC) as does the U.S. white population. CRC screening allows 
early detection and prevention of cancer.
Objective—We describe pilot projects conducted from 2005 to 2010 to increase CRC screening 
rates among AN populations living in rural and remote Alaska.
Design—Projects included training rural mid-level providers in flexible sigmoidoscopy, 
provision of itinerant endoscopy services at rural tribal health facilities, the creation and use of a 
CRC first-degree relative database to identify and screen individuals at increased risk, and support 
and implementation of screening navigator services.
Setting—Alaska Tribal Health System.
Patients—AN population.
Interventions—Itinerant endoscopy, patient navigation.
Main Outcome Measurements—AN patients screened for CRC, colonoscopy quality 
measures.
Results—As a result of these ongoing efforts, statewide AN CRC screening rates increased from 
29% in 2000 to 41% in 2005 before the initiation of these projects and increased to 55% in 2010. 
The provision of itinerant CRC screening clinics increased rural screening rates, as did outreach to 
average-risk and increased-risk (family history) ANs by patient navigators. However, health care 
system barriers were identified as major obstacles to screening completion, even in the presence of 
dedicated patient navigators.
Limitations—Continuing challenges include geography, limited health system capacity, high 
staff turnover, and difficulty getting patients to screening appointments.
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Conclusions—The projects described here aimed to increase CRC screening rates in an 
innovative and sustainable fashion. The issues and solutions described may provide insight for 
others working to increase screening rates among geographically dispersed and diverse 
populations.
Among the Alaska Native (AN) population, cancer is the leading cause of death, and 
colorectal cancer (CRC) is the second leading cause of cancer death.1 For the period 2004 to 
2008, the AN age-adjusted CRC mortality and incidence rates were about twice those of the 
U.S. white population.2,3 The AN population also have the highest CRC incidence of all 
Native American groups, with a CRC incidence that is nearly 5 times higher than that of 
American Indians living in the U.S. Indian Health Services Southwest Region.4 The reasons 
for these regional disparities are unclear; nonetheless, the morbidity and mortality of CRC 
can be reduced in all regions by population-based screening and surveillance programs that 
include endoscopy (colonoscopy and flexible sigmoidoscopy) and fecal occult blood tests. 
Screening can detect advanced neoplasia (polyps and cancer) and, in the case of endoscopy, 
can even prevent cancer by removing precancerous polyps.5,6
BACKGROUND
The Alaska Tribal Health System (ATHS) provides health care for the AN population, who 
belong to 3 major ethnic groups: Eskimo, Aleut, and American Indian. Approximately half 
of the 125,000 AN people in the state live in rural and remote communities that are off the 
road system and are accessible only by small aircraft, snowmobiles, or boats.7,8 The ATHS 
is a spoke-and-hub system consisting of small tribal village clinics, subregional clinics, and 
regional hospitals, with 1 tertiary care hospital (Alaska Native Medical Center [ANMC]) in 
Anchorage. The tribal village clinics are staffed by community health aides/practitioners 
who are laypersons trained as first responders in emergencies and who provide basic 
primary and preventive health care. Subregional clinics are staffed by community health 
aides/practitioners, physician assistants, and nurse practitioners. Regional hospitals provide 
inpatient, outpatient, and emergency services and are staffed by physician assistants, nurse 
practitioners, and physicians.8 CRC screening in Alaska is challenging because of the 
unique geography and climate, which often necessitate long-distance, high-cost air travel to 
access endoscopy services (Fig. 1).
Formed in 1997, the Alaska Native Tribal Health Consortium (ANTHC) is a statewide 
nonprofit health services organization owned and operated by the AN people to provide 
health services to members of the 229 tribes throughout Alaska and to support the tribal 
health organizations that comprise the ATHS. In 1994, Alaska Tribes and Tribal 
representatives signed the Alaska Tribal Health Compact with the U.S. Department of 
Health And Human Services Indian Health Service for management of all statewide health 
services formerly provided by that agency for the AN population. In the late 1990s, ANTHC 
began endoscopy training for nurse practitioners and physician assistants to improve access 
to screening flexible sigmoidoscopy and colonoscopy. These initial efforts led to the 
collaboration in 2004 of the ANTHC Alaska Native Epidemiology Center and the Centers 
for Disease Control and Prevention Division of Cancer Prevention and Control.
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This article was reviewed and approved by ANTHC tribal review committee on behalf of 
the ANTHC Board of Directors. It was also approved for clearance by the Centers for 
Disease Control and Prevention, which funded the pilot projects. This article describes the 
implementation and outcome of 3 pilot projects to improve CRC screening rates among the 
AN population in the ATHS. We describe facilitators and barriers to CRC screening and 
highlight considerations for others working to increase screening rates among 
geographically and ethnically diverse populations.
PILOT PROJECT DESCRIPTIONS
Endoscopy
Fecal occult blood tests are not recommended for use in the AN population because of a 
high prevalence of Helicobacter pylori–associated hemorrhagic gastritis, which results in 
high false-positive rates,9,10 making lower endoscopy (flexible sigmoidoscopy and 
colonoscopy) the preferred screening method for CRC. However, endoscopy is routinely 
available in Alaska only in Anchorage and 2 of the 7 regional hospitals. For patients living 
in areas not directly served at regional centers, access to endoscopic services are limited to 
biyearly specialty field clinics staffed by Anchorage-based providers or travel to the ANMC 
in Anchorage. Because of the limited time frame of these field clinics, patients in need of 
diagnostic examinations are given priority over screening procedures. Although endoscopic 
equipment is available in other regional hospitals, providers there are either untrained in the 
procedures or are not allotted time to conduct them because of competing clinical 
responsibilities for providers and support staff.11 Therefore, endoscopy at the regional level 
prioritizes symptomatic patients ahead of screening patients.
We previously described efforts to increase flexible sigmoidoscopy screening services in 
rural areas by training mid-level health care providers.11 In the late 1990s, an internal review 
of medical records at the ANMC found that only 10% of the age-eligible AN population 
served by the ANMC had been screened for CRC. To address this issue, the ANMC Surgery 
Department trained a physician assistant to perform screening with flexible sigmoidoscopy. 
In 2000, CRC screening services were expanded by recruiting and training a nurse 
practitioner for a dedicated screening flexible sigmoidoscopy clinic at the ANMC. CRC 
screening rates in the Anchorage area improved dramatically with the initiation of this 
screening clinic. As a result of these combined efforts, the percentage of age-eligible ANs in 
the Anchorage area screened for CRC increased rapidly to 47% by December 2003, 
representing a fivefold increase.12 Based on this success, we then developed a flexible 
sigmoidoscopy training program for nurse practitioners and physician assistants from 
regional hub communities across the state. The curriculum included didactic and clinical 
skills components. Seven providers were trained from 2005 to 2009, and, as a result, 205 
rural patients underwent screening flexible sigmoidoscopies. However, by the end of 2009, 
only 1 trainee continued to perform screening examinations. Factors affecting attrition 
included staff turnover, competing clinical priorities, and a general shift to colonoscopy as 
the preferred screening modality for this high-risk population.11
As a result of the limited success of the flexible sigmoidoscopy training program for 
nonphysicians, ANTHC shifted focus in 2007 to supporting itinerant screening colonoscopy 
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field clinics. In this model, an endoscopist from the ANMC travels to remote areas of Alaska 
to conduct CRC screenings at 3 regional hospitals with clinic space available for endoscopy. 
Priority is given to patients who have never been screened and to those individuals who have 
a family history of CRC or adenomatous polyps in 1 or more first-degree relatives. Patients 
in whom CRC is found are referred to the ANMC in Anchorage for further care.
Two models of financial support for colonoscopy screening were piloted from 2007 to 2009: 
(1) a capitated model in which payment was determined by the number of colonoscopies 
performed, and (2) a flat day-rate model in which funding was based on a certain number of 
days of endoscopist time, regardless of the number of screenings completed in that period. 
Each facility was required to report data on patient demographics, number of patients 
screened, cancellation and “no-show” rates, screening history, personal and/or family history 
of CRC and/or colonic polyps, and pathology outcomes. In 2008, we added quality of care 
measures to the data-reporting requirements using national quality standards.13,14 These 
measures included the cecal intubation rate, adenoma detection rate, and colonoscopy 
complication rate. Colonoscope withdrawal time was not added until the end of the project 
and is not reported here.
Approximately 3828 AN patients who received care through the regional tribal health 
organizations were due for colonoscopy screening at the beginning of the project period. As 
a result of the itinerant clinic project, a total of 290 AN individuals were screened for CRC 
by colonoscopy at 3 different rural sites (Table 1). Each of the 3 regions comprised remote 
AN communities scattered over an area ranging in size from 36,000 to 98,000 square miles, 
including many communities that could only be reached by small aircraft. Cancellation rates 
ranged from 25% to 54% (mean 37%) with an additional “no-show” rate of 4% to 10% 
(mean 7%). The proportion of cancellations that were rescheduled and completed was not 
recorded. The most common reasons for patient cancellation were weather (19%), acute 
medical issues (13%), and work constraints (13%). Other reasons given (37%) for 
cancellation were lack of child care, other competing priorities, or a desire to get the 
screening examination done in Anchorage instead of at the regional health facility. The 
proportion of men (48%) and women (52%) screened was about equal. The majority of 
patients (70%) came from very small communities (average size of 400 persons) 
surrounding the regional hub community where the screening procedures were completed.
From 36% to 90% (mean 61%) of patients had never been screened previously for CRC. A 
family history of CRC was reported by 10% to 20% (mean 17%) of patients, whereas a 
personal history of CRC or polyps was reported by 10% to 46% (mean 20%) of patients. 
From 32% to 41% (mean 35%) of patients had at least 1 adenoma found on the screening 
examination. Colonoscopy quality was high; the cecal intubation rate was 93% and the 
average adenoma detection rate was 35%. The complication rate was 1% because of a single 
perforation that did not require hospitalization.
First-degree relative outreach
Family history is a critical component of CRC risk stratification.6,15 In 2007, the ANTHC 
began systematically asking CRC patients seen at the ANMC for permission to contact their 
first-degree relatives. If they agree, CRC patients are approached for a contact list of 
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relatives at one of the following times: while still in the hospital, when coming back for 
follow-up appointments, or via a form sent with a business reply envelope to their home. 
Since the project began, only 3 of 588 patients (0.5%) have declined to give lists of their 
first-degree relatives. The contact information is entered into a computerized database. A 
CRC screening patient navigator then uses this information to provide direct outreach to AN 
family members to encourage them to get screened for CRC as appropriate. Contact of first-
degree relatives is conducted by telephone and mailed reminder letters. Lists of first-degree 
relatives in need of screening are also sent annually to regional tribal medical and clinical 
directors for outreach by their facility. As of March 1, 2011, there were 588 CRC cases and 
1444 first-degree relatives in the database. On average, about 3 first-degree relatives were 
identified per CRC case. A total of 661 first-degree relatives were due for screening; 465 
were screened, 194 were not due yet (too young), and 124 were missing contact information 
such that they could not be identified for outreach. A total of 221 relatives included in the 
database were screened before the initiation of the Patient Navigator project. From the 
initiation of outreach efforts in January, 2007, to March 1, 2011, a total of 600 persons were 
reached out to and 254 first-degree relatives were screened for CRC as a result of the 
outreach efforts. Of the 254 persons screened, 58% had normal findings on examinations, 
22% had tubular adenomas, 4% had tubulovillous or villous adenomas, and 5% had 
adenocarcinomas. The results from 26 individuals (5%) were unable to be ascertained from 
the medical record.
Patient navigation
To build on the success of navigation among individuals with a family history of CRC, from 
April 2009 through March 2010, the ANTHC partnered with a regional tribal health 
organization to implement the CRC Screening Patient Navigator Demonstration Project. A 
patient navigator was hired to guide average-risk asymptomatic patients through the 
screening process by encouraging them to obtain screening appointments, called patients to 
remind them about upcoming appointments, ensured that they had a transportation plan, 
answered questions about bowel preparation, and tracked screening results to ensure that 
appropriate follow-up was completed.
Approximately 1431 AN patients who received care through the regional tribal health 
organization were due for colonoscopy screening at the beginning of the project period. The 
patient navigator conducted direct outreach to 336 patients eligible for screening, with a 
total of 1047 contact attempts (average 28–41 per month). More than half (58%) of the 
outreach was in the form of phone calls, with 36% mailed letters, 2% e-mail, 3% provider 
contacts, and 2% other methods (eg, personal encounters, chart review). At the end of the 
project period, 46 patients (14%) completed CRC screening as a result of the patient 
navigator’s efforts and 22 referrals were still in progress. The majority of the patients 
screened (89%) had never been screened before, 39% had a family history of CRC, and 
about half (54%) were men. As a result of the screening, tubular or villous adenomatous 
polyps were found in 33% of patients, and 2 patients were found to have adenocarcinomas. 
Of the 2 cancers found, 1 was in a patient who had a history of CRC and the other in an 
individual who had never been screened before.
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Although the patient navigation system was successful at targeting patients who had never 
been screened or who had a family history of CRC, fewer patients completed screening than 
was hoped. Health care system barriers were identified as a major obstacle to screening 
completion. The tribal health organization surgery department required that all patients have 
a precolonoscopy physical examination, laboratory tests and blood work, and an 
electrocardiogram. Most of the primary care providers who referred patients did not know 
all of the medical clearance procedures that patients needed to complete before they could 
get screened. Additionally, there were long delays in availability of these precolonoscopy 
appointments. It could take as long as 10 weeks from the time of referral by a primary care 
provider or outreach call from the patient navigator to the actual screening colonoscopy. The 
patient navigator spent most of her time helping patients understand and obtain all the 
necessary appointments in a timely manner, which resulted in less time available for 
outreach to new patients. The patient navigator assisted with communication between 
clinical case managers and patients regarding transportation from small communities to the 
regional health facility.
Since the end of the project, the regional tribal health organization has addressed many of 
these systems-level barriers to screening. They have now developed a streamlined medical 
protocol for colonoscopy referrals and a training program for their case managers and 
primary care providers so that all are aware of the medical clearance requirements at the 
organization. Additionally, the position of a patient care coordinator is being created; that 
person would facilitate patient travel, help patients with bowel preparation instruction, and 
continue outreach to patients.
DISCUSSION
The overall CRC screening rate in the ATHS has improved from 29% of AN patients in 
2000 to 41% in 2005 before the initiation of these projects. Screening rates increased to 55% 
in 2010.16 CRC screening included colonoscopy in the past 10 years or flexible 
sigmoidoscopy in past 5 years. Although it is widely accepted that CRC screening saves 
lives and overall AN screening rates have increased, regional rates still range from 23% to 
68%, indicating a need for continued targeted screening efforts, especially in rural and 
remote areas.
The size and geography of Alaska can present formidable barriers to obtaining access to 
health care, including cancer screening services. This article describes 3 projects in the 
ATHS to increase CRC screening rates among AN men and women. Our previous project to 
train mid-level rural providers in flexible sigmoidoscopy was successful in getting providers 
trained but ultimately unsuccessful in significantly increasing screening rates because of 
staff turnover, competing clinical priorities, and a general shift to colonoscopy as the 
preferred screening modality. We found that using itinerant endoscopists to perform periodic 
screening clinics in regional health facilities appears to be the most effective and sustainable 
model for screening in rural areas. This is not surprising given that this strategy overcomes 
many inherent barriers to screening, especially patient travel. From a health system 
standpoint, it is significantly more cost-effective to bring the provider to the patients than to 
bring the patients to the provider. All of the organizations involved have continued to use 
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the itinerant endoscopy model to provide screening of their patient population using their 
own funding sources after the end of the project period. Additionally, this pilot project led to 
a greater emphasis at the tribal health organizations involved in the project to do health 
promotion around cancer screening.
The quality of colonoscopic examinations in the itinerant endoscopist model was high. 
Overall, the cecum was reached in 93% of examinations. Additionally, the adenoma 
detection rate was 35%, far exceeding the national quality guidelines set for men (≥25%) 
and women (≥15%).17 Because of the high incidence of cancer in the AN population, the 
prevalence of H pylori infection, and the high adenoma detection rates documented by these 
pilot projects, endoscopy remains the preferred test for screening this high-risk population. 
However, nonendoscopy-based screening methods should be explored to increase the 
number of AN individuals screened for this disease.
Providing targeted outreach to family members of CRC patients was effective at achieving 
screening uptake among individuals at increased risk of CRC. Patient navigation is a way to 
improve effectiveness of care and increase screening rates, especially among low-income 
and minority populations.18–20 We found that patient navigation and targeted outreach were 
effective at increasing screening rates, but were sometimes hampered by system-level 
barriers. Health systems need to include efficient ways to provide screening including 
simplified prescreening procedures for asymptomatic low-risk patients and the use of direct 
endoscopic referral.21 We recommend that patient navigation programs conduct a screening 
referral process flow assessment in the start up phase to identify potential barriers before 
program initiation. Patient navigation programs must also be fully integrated into clinic flow 
systems.
A limitation of the programs presented here was that data were not collected on resource use 
and related costs for CRC screening. Therefore, analyses of costs are not possible. Further 
research on relative costs may help inform the development of organized CRC programs.22 
Another limitation of the study is the heterogeneous nature of the ATHS, which includes 
multiple regional tribal health facilities. This heterogeneity makes it more difficult to draw 
conclusions as to best practices in promoting CRC screening among all AN men and 
women. However, we have found that even if screening and/or travel for screening are 
financially covered, other barriers, such as system-level issues, still exist. Because of this, 
we have increasingly focused on expanding patient navigation, education, and outreach 
efforts to ensure greater numbers of patients receive recommended CRC screening. 
Continued efforts to address and respond to these types of challenges will help to increase 
CRC screening and ultimately reduce the disparities in CRC morbidity and mortality among 
the AN population.
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• Increasing colorectal cancer (CRC) screening among rural and remote Alaska 
Native populations requires exploration of multiple methods, including travel by 
itinerant endoscopists to regional communities and increased patient navigation 
services.
• By addressing geographic and community-level barriers, the Alaska Tribal 
Health System was able to successfully increase CRC screening rates among 
Alaska Native populations.
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Alaska Native health care referral pattern distances compared with United States land mass.
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